Certain Cancer Diagnoses Up in High-Income Counties in U.S.

Share this content:
Certain Cancer Diagnoses Up in High-Income Counties in U.S.
Certain Cancer Diagnoses Up in High-Income Counties in U.S.

THURSDAY, June 8, 2017 (HealthDay News) -- Americans living in high-income areas are more likely to be diagnosed with some types of cancer than people living in low-income areas, according to a perspective piece published in the June 8 issue of the New England Journal of Medicine.

The study authors analyzed data on four types of cancers (breast, prostate, melanoma, and thyroid) in high-income counties (median annual income above $75,000) and low-income counties (median annual income less than $40,000).

High-income counties had far higher diagnosis rates for the four cancers than low-income counties, but the combined mortality rate was similar for both. That suggests rates of these cancers are actually similar in high- and low-income counties, the researchers said.

"Doctors and other health care professionals tend to overstate the role of medical testing in promoting health -- particularly in people who aren't sick," study coauthor H. Gilbert Welch, M.D., M.P.H., a professor of community and family medicine at the Dartmouth Institute for Health Policy and Clinical Practice in Lebanon, N.H., said in an institute news release. "A healthy diet, regular exercise, and a sense of purpose are very often the best tools people, at every income level, have to maintain good health."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »